Therapeutic Targets Database
BIDD Pharmainformatics Databases


Target Validation Information
Target NameVoltage-dependent T-type calcium channel alpha-1G subunit    
Type of TargetSuccessful target    
Drug Potency against TargetMethsuximideIC50 = 1100000 nM[1]
PregabalinIC50 = 16800 nM[2]
VerapamilIC50 = 250 nM[3]
TrimethadioneIC50 = 369000 nM[4]
EthosuximideIC50 = 7000 nM[1]
cis-N,5-dibenzyl-6-oxomorpholine-3-carboxamideIC50 = 1010 nM[5]
KYS-05065IC50 = 1040 nM[6]
KYS-05042IC50 = 110 nM[6]
KYS-05042IC50 = 110 nM[7]
KYS-05001IC50 = 1160 nM[8]
KYS-05050IC50 = 130 nM[9]
KYS-05040IC50 = 14400 nM[10]
KKHT-20818IC50 = 1520 nM[11]
KKHT-10608IC50 = 16870 nM[11]
KYS-05041IC50 = 170 nM[7]
KKHT-20918IC50 = 1950 nM[11]
KKHT-10618IC50 = 2080 nM[11]
KKHT-10318IC50 = 2460 nM[11]
KYS-05041IC50 = 250 nM[12]
KYS-05080IC50 = 260 nM[6]
KKHT-11018IC50 = 3380 nM[11]
KYS-05055IC50 = 350 nM[6]
KKHT-20718IC50 = 3720 nM[11]
KYS-05056IC50 = 380 nM[6]
KYS-05090IC50 = 41 nM[6]
KYS-05077IC50 = 4200 nM[9]
KYS-05057IC50 = 630 nM[6]
KKHT-10609IC50 = 9230 nM[11]
KYS-05064IC50 = 960 nM[12]
Ref 1J Bioenerg Biomembr. 2003 Dec;35(6):577-98.Modulation and pharmacology of low voltage-activated ("T-Type") calcium channels. To Reference
Ref 2Neuropharmacology. 2002 Feb;42(2):229-36.Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex. To Reference
Ref 3Life Sci. 1982 Oct 11;31(15):1575-85.Specific calcium antagonist binding sites in brain. To Reference
Ref 4Life Sci. 1988;43(6):477-84.Evidence for involvement of the astrocytic benzodiazepine receptor in the mechanism of action of convulsant and anticonvulsant drugs. To Reference
Ref 5Bioorg Med Chem Lett. 2006 Oct 1;16(19):5244-8. Epub 2006 Jul 28.Morpholin-2-one derivatives as novel selective T-type Ca2+ channel blockers. To Reference
Ref 6Bioorg Med Chem Lett. 2008 Jul 15;18(14):3899-901. Epub 2008 Jun 14.T-type Ca2+ channel blockers suppress the growth of human cancer cells. To Reference
Ref 7Bioorg Med Chem Lett. 2005 Jan 17;15(2):283-6.Synthesis and biological activity of 3,4-dihydroquinazolines for selective T-type Ca2+ channel blockers. To Reference
Ref 8Bioorg Med Chem Lett. 2007 Nov 1;17(21):5740-3. Epub 2007 Sep 1.Discovery of potent T-type calcium channel blocker. To Reference
Ref 9Bioorg Med Chem Lett. 2007 Jan 15;17(2):471-5. Epub 2006 Oct 12.Synthesis and biological evaluation of novel T-type calcium channel blockers. To Reference
Ref 10Bioorg Med Chem Lett. 2004 Jul 5;14(13):3379-84.3,4-Dihydroquinazoline derivatives as novel selective T-type Ca2+ channel blockers. To Reference
Ref 11Bioorg Med Chem. 2007 Jan 1;15(1):365-73. Epub 2006 Oct 10.Novel T-type calcium channel blockers: dioxoquinazoline carboxamide derivatives. To Reference
Ref 12Bioorg Med Chem. 2007 Jan 15;15(2):1091-105. Epub 2006 Oct 30.3D pharmacophore based virtual screening of T-type calcium channel blockers. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543